# Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

> **NCT04262765** · PHASE1 · COMPLETED · sponsor: **Midas Pharma GmbH** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Ramipril, Amlodipine and Atorvastatin

## Key facts

- **NCT ID:** NCT04262765
- **Lead sponsor:** Midas Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-23
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04262765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04262765, "Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04262765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*